sanjivani parental.....update

the stock has fallen frm 60 levels to present 39 levels....i think i shld start acccumulating frm these levels n keeep a long term view....minimum 6-8 months...can definately turn to be a multibagger if hold on to 12-15 months

A leading manufacturer the injectibles space,Sanjivani Paranteral has been making inroads not only the domestic market but also in the lukrative export markets.With an eye on further growth,the company is set to expand it's capacities and introduce new products.By March 2006,it will launch ANTI-CANCER injectibles both the domestic and export market.Presently ,it manufactures seven million units of injectibles per month.With its dealer network in 14 states across India,the company has made good penetration the domestic market for it's products.Given the portfolio of its high quality medicines,it has become a major supplier to many reputed companies and public institutions. order to expand it's market spread,it is now eyeing the overseas market.recently it succeeded in regestering two of its products in the CIS .This initiative will allow the company to export directly to these countries.On the overseas front ,the company is targeting the markets of Sri Lanka,Malaysia,senegal and South africa where registration procedure for different products is on and according to Mr Khemka,the impact of thsi activity will be seen Q4 of FY 2006.The company is planning to set up a new facility witha capex of 25 crore to 28 crore very soon,for which the place has been identified.to partly meet the expenditure.last year,the copmay raised rs 6 crore by way of preferential allottment.It has also tied up with a UK-based company,which will part finance the copmay's upcomong project in teh from of avances to be settled against supplies to that company.The company thus can spread its wings the European,South African,Gulf and Ruusian markets through these ties.It expectsa 100 % growth on y-o-y basis in future with the bulk chunk of revenues coming from its proposed anti cancer injectibles.The new unit will be exporting to the semi-regulated markets through its foreign tie-up. future compay will also come up with injectibles the anti-diabetes and cardiac segments."Once our expansion exercise is over,we expect a 100 per cent growth our top line" avers Mr Khemka